M. Chomarat

1.0k total citations
46 papers, 685 citations indexed

About

M. Chomarat is a scholar working on Infectious Diseases, Epidemiology and Clinical Biochemistry. According to data from OpenAlex, M. Chomarat has authored 46 papers receiving a total of 685 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Infectious Diseases, 15 papers in Epidemiology and 12 papers in Clinical Biochemistry. Recurrent topics in M. Chomarat's work include Bacterial Identification and Susceptibility Testing (12 papers), Antimicrobial Resistance in Staphylococcus (10 papers) and Streptococcal Infections and Treatments (8 papers). M. Chomarat is often cited by papers focused on Bacterial Identification and Susceptibility Testing (12 papers), Antimicrobial Resistance in Staphylococcus (10 papers) and Streptococcal Infections and Treatments (8 papers). M. Chomarat collaborates with scholars based in France, Laos and Japan. M. Chomarat's co-authors include Jean‐Pierre Flandrois, Antonio Goglio, Gorm Lisby, H.‐U. SCHUSTER, Andreas Hoeft, Boris Böddinghaus, H. Wissing, Alfredo Raglio, Vanya Gant and Henrik Westh and has published in prestigious journals such as Clinical Infectious Diseases, The American Journal of Medicine and Journal of Clinical Microbiology.

In The Last Decade

M. Chomarat

45 papers receiving 649 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. Chomarat France 12 332 231 209 127 103 46 685
A Digranes Norway 17 310 0.9× 172 0.7× 193 0.9× 91 0.7× 90 0.9× 46 747
W. R. Heizmann Germany 17 233 0.7× 155 0.7× 172 0.8× 86 0.7× 98 1.0× 57 737
Asbjørn Digranes Norway 15 435 1.3× 134 0.6× 315 1.5× 95 0.7× 53 0.5× 55 794
Virginia H. Morthland United States 16 321 1.0× 274 1.2× 510 2.4× 89 0.7× 179 1.7× 22 922
Gerald A. Denys United States 17 384 1.2× 154 0.7× 246 1.2× 83 0.7× 93 0.9× 46 850
R L Kaplan United States 12 298 0.9× 161 0.7× 256 1.2× 65 0.5× 40 0.4× 17 616
H. Mittermayer Austria 17 250 0.8× 185 0.8× 324 1.6× 61 0.5× 188 1.8× 46 843
A Kureishi Canada 15 305 0.9× 88 0.4× 263 1.3× 63 0.5× 166 1.6× 20 879
M. Gurguí Spain 14 478 1.4× 121 0.5× 182 0.9× 155 1.2× 58 0.6× 19 739
Carlos Fernández-Mazarrasa Spain 11 431 1.3× 135 0.6× 262 1.3× 93 0.7× 56 0.5× 15 715

Countries citing papers authored by M. Chomarat

Since Specialization
Citations

This map shows the geographic impact of M. Chomarat's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Chomarat with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Chomarat more than expected).

Fields of papers citing papers by M. Chomarat

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Chomarat. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Chomarat. The network helps show where M. Chomarat may publish in the future.

Co-authorship network of co-authors of M. Chomarat

This figure shows the co-authorship network connecting the top 25 collaborators of M. Chomarat. A scholar is included among the top collaborators of M. Chomarat based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Chomarat. M. Chomarat is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Somphavong, Silaphet, Yves Buisson, Nicolas Steenkeste, et al.. (2013). Resistance of Mycobacterium tuberculosis to antibiotics in Lao PDR: first multicentric study conducted in 3 hospitals. BMC Infectious Diseases. 13(1). 275–275. 9 indexed citations
2.
Bouzbid, S., et al.. (2011). Automated detection of nosocomial infections: evaluation of different strategies in an intensive care unit 2000–2006. Journal of Hospital Infection. 79(1). 38–43. 30 indexed citations
3.
Joly‐Guillou, Marie‐Laure, Marie Kempf, Jean-Didier Cavallo, et al.. (2010). Comparative in vitro activity of Meropenem, Imipenem and Piperacillin/tazobactam against 1071 clinical isolates using 2 different methods: a French multicentre study. BMC Infectious Diseases. 10(1). 72–72. 44 indexed citations
4.
Westh, Henrik, Gorm Lisby, Boris Böddinghaus, et al.. (2009). Multiplex real-time PCR and blood culture for identification of bloodstream pathogens in patients with suspected sepsis. Clinical Microbiology and Infection. 15(6). 544–551. 184 indexed citations
5.
Singer, Elisabeth, F. Mory, C. Muller, et al.. (2008). Surveillance de la résistance aux antibiotiques des anaérobies stricts à Gram négatif. Médecine et Maladies Infectieuses. 38(5). 256–263. 9 indexed citations
6.
Delmas, Julien, et al.. (2006). Rapid identification of Enterobacteriaceae by sequencing DNA gyrase subunit B encoding gene. Diagnostic Microbiology and Infectious Disease. 55(4). 263–268. 35 indexed citations
7.
Chomarat, M., et al.. (2005). Étude du portage rhinopharyngé de Streptococcus pneumoniae chez les enfants sains âgés de 2 à 24 mois en Nouvelle-Calédonie. Médecine et Maladies Infectieuses. 35(10). 500–506. 10 indexed citations
8.
Behra-Miellet, Josette, F. Mory, C. Muller, et al.. (2003). Antibiotic resistance among anaerobic Gram-negative bacilli: lessons from a French multicentric survey. Anaerobe. 9(3). 105–111. 43 indexed citations
9.
Chomarat, M.. (2000). Resistance of bacteria in urinary tract infections. International Journal of Antimicrobial Agents. 16(4). 483–487. 54 indexed citations
10.
Chomarat, M., et al.. (1998). MOLECULAR ANALYSIS OF THE FISH PATHOGEN AEROMONAS SALMONICIDA SUBSP. SALMONICIDA BY PULSED-FIELD GEL ELECTROPHORESIS. Revue Méd Vét. 149(3). 245–250. 6 indexed citations
11.
Frédénucci, Isabelle, M. Chomarat, Catherine Boucaud, & Jean‐Pierre Flandrois. (1998). Saccharomyces boulardiiFungemia in a Patient Receiving Ultra‐levure Therapy. Clinical Infectious Diseases. 27(1). 222–223. 39 indexed citations
12.
Guérin‐Faublée, Véronique, Sandrine Charles, M. Chomarat, & Jean‐Pierre Flandrois. (1997). Reappraisal of the effect of temperature on the growth kinetics of Aeromonas salmonicida. Letters in Applied Microbiology. 25(5). 363–366. 3 indexed citations
13.
Chomarat, M., et al.. (1997). Tonsillar diffusion kinetics of amoxycillin after oral administration of 1 g to adults. European Journal of Drug Metabolism and Pharmacokinetics. 22(2). 141–144. 4 indexed citations
14.
Monneret, Guillaume, et al.. (1996). Fatal Septic Shock with Multiple Organ Failure Due to Campylobacter jejuni. Clinical Infectious Diseases. 22(1). 183–184. 6 indexed citations
15.
Branger, Catherine, Joëlle Fournier, J. Loulergue, et al.. (1994). Epidemiology ofStaphylococcus aureusin patients with cystic fibrosis. Epidemiology and Infection. 112(3). 489–500. 21 indexed citations
16.
Chomarat, M., et al.. (1991). Susceptibility to Aminoglycosides of 63 Strains of Stomatococcus mucilaginosus Isolated from Sputum. Zentralblatt für Bakteriologie. 276(1). 63–67. 3 indexed citations
17.
Chomarat, M., Yoshitoshi Ichiman, & Kenichi Yoshida. (1989). Protection of mice by a pseudodiffuse strain of Staphylococcus aureus possessing polyvalent capsular type antigen. Journal of Medical Microbiology. 28(2). 129–136. 3 indexed citations
18.
Chomarat, M. & Annie Rochette. (1988). Signification de l'isolement de Stomatococcus mucilaginosus. La Presse Médicale. 17(11). 537–538. 1 indexed citations
19.
Lepape, Alain, et al.. (1988). Corynebacterium JK: surgical infections in non-immunosuppressed patients. Intensive Care Medicine. 15(1). 23–6. 1 indexed citations
20.
Chomarat, M., et al.. (1985). Septicémie à Pseudomonas pickettii. 33(1). 55–56. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by A Digranes Breakdown of academic impact, for papers by W. R. Heizmann Breakdown of academic impact, for papers by Asbjørn Digranes Breakdown of academic impact, for papers by Virginia H. Morthland Breakdown of academic impact, for papers by Gerald A. Denys Breakdown of academic impact, for papers by R L Kaplan Breakdown of academic impact, for papers by H. Mittermayer Breakdown of academic impact, for papers by A Kureishi Breakdown of academic impact, for papers by M. Gurguí Breakdown of academic impact, for papers by Carlos Fernández-Mazarrasa
Rankless by CCL
2026